| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| Other Sizes |
|
| Targets |
Human Endogenous Metabolite
|
|---|---|
| ln Vitro |
G-actin polymerization is observed after 12 and 24 hours of treatment with TRIA-662 (0.1–10 μM) [1]. Endothelial cells demonstrate anti-inflammatory effect towards TRIA-662 (0.05-0.2 μM; 1-24 hours) [1].
|
| Cell Assay |
Immunofluorescence[1]
Cell Types: HMECs Tested Concentrations: 0.1 and 10 μM Incubation Duration: 12 and 24 hrs (hours) Experimental Results: demonstrated polymerization of the G-actin, and strong, clearly visible, parallel F-actin fibers at 10 μM. |
| References |
| Molecular Formula |
C7H9CLN2O
|
|---|---|
| Molecular Weight |
172.61
|
| Exact Mass |
172.04
|
| CAS # |
1005-24-9
|
| Related CAS # |
TRIA-662-d3;1218993-18-0
|
| PubChem CID |
70495
|
| Appearance |
Typically exists as solid at room temperature
|
| Melting Point |
207-209℃ (water acetone )
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
11
|
| Complexity |
136
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[Cl-].O=C(C1C([H])=C([H])C([H])=[N+](C([H])([H])[H])C=1[H])N([H])[H]
|
| InChi Key |
BWVDQVQUNNBTLK-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C7H8N2O.ClH/c1-9-4-2-3-6(5-9)7(8)10;/h2-5H,1H3,(H-,8,10);1H
|
| Chemical Name |
1-methylpyridin-1-ium-3-carboxamide;chloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O: 110 mg/mL (637.27 mM)
DMSO: 2 mg/mL (11.59 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (7.24 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (7.24 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. View More
Solubility in Formulation 3: 100 mg/mL (579.34 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.7934 mL | 28.9670 mL | 57.9341 mL | |
| 5 mM | 1.1587 mL | 5.7934 mL | 11.5868 mL | |
| 10 mM | 0.5793 mL | 2.8967 mL | 5.7934 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
